Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Ankylosing Spondylitis”

18 trials

Showing 18 of 18 results

Large-scale testing (Phase 3)Study completedNCT01040195
What this trial is testing

Combination Disease-Modifying Antirheumatic Drugs (DMARDs) Versus Sulfasalazine in Inflammatory Back Pain

Who this might be right for
Seronegative Spondyloarthropathies
Sanjay Gandhi Postgraduate Institute of Medical Sciences 33
Large-scale testing (Phase 3)UnknownNCT00889694
What this trial is testing

Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis

Who this might be right for
Early Ankylosing Spondylitis
Sun Yat-sen University 80
Large-scale testing (Phase 3)Study completedNCT00844805
What this trial is testing

Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)

Who this might be right for
Ankylosing SpondylitisAxial Spondyloarthritis
Merck Sharp & Dohme LLC 158
Not applicableStudy completedNCT01302730
What this trial is testing

Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study

Who this might be right for
Ankylosing SpondylitisSpondylarthritis
Stanford University 490
Not applicableStudy completedNCT04507763
What this trial is testing

Study To Evaluate The Impact Of Early Initiation Of Biological Treatment With Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Pfizer 763
Post-approval studies (Phase 4)Study completedNCT00936143
What this trial is testing

Efficacy and Safety Study of Infliximab (Remicade) to Treat Early Ankylosing Spondylitis

Who this might be right for
Spondylitis
Gu Jieruo 70
Testing effectiveness (Phase 2)UnknownNCT00844142
What this trial is testing

Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)

Who this might be right for
Moderate to Severe Active Axial Spondyloarthritis
Charite University, Berlin, Germany 80
Not applicableUnknownNCT00328068
What this trial is testing

Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)

Who this might be right for
SpondyloarthritisSpondylarthropathySpondylitis, Ankylosing
Charite University, Berlin, Germany 992
Testing effectiveness (Phase 2)Ended earlyNCT02328027
What this trial is testing

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Who this might be right for
Rheumatoid ArthritisAnkylosing Spondylitis
Advanced Accelerator Applications 16
Post-approval studies (Phase 4)Study completedNCT00953979
What this trial is testing

Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis

Who this might be right for
Ankylosing SpondylitisTreatment
Gu Jieruo 126
Not applicableStudy completedNCT00383617
What this trial is testing

Referral Recommendations for Axial Spondyloarthritis

Who this might be right for
SpondyloarthropathyAnkylosing SpondylitisSpondyloarthritis
Charite University, Berlin, Germany 500
Large-scale testing (Phase 3)Study completedNCT01258738
What this trial is testing

Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes

Who this might be right for
Spondylitis, Ankylosing
Pfizer 225
Early research (Phase 1)Not Yet RecruitingNCT07632599
What this trial is testing

Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Eighth Affiliated Hospital, Sun Yat-sen University 40
Post-approval studies (Phase 4)WithdrawnNCT01148901
What this trial is testing

Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451)

Who this might be right for
Ankylosing Spondylitis
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)UnknownNCT00235105
What this trial is testing

D2E7-Early AS

Who this might be right for
Ankylosing Spondylitis
Charite University, Berlin, Germany 46
Not applicableStudy completedNCT04095169
What this trial is testing

Biomarkers in Early-stage Spondyloarthritis

Who this might be right for
Ankylosing SpondylitisSpondyloarthritis
Spine Centre of Southern Denmark 216
Not applicableStudy completedNCT02311842
What this trial is testing

To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS

Who this might be right for
Ankylosing Spondylitis
Sun Yat-sen University 68
Not applicableStudy completedNCT01709656
What this trial is testing

A Molecule Basic Study of Early Warning for New Pathogenic Risk of Ankylosing Spondylitis

Who this might be right for
Ankylosing Spondylitis
Sun Yat-sen University 120

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation